Publications<< Back
Cid J, Carbassé G, Andreu B, Baltanás A, Garcia-Carulla A, Lozano M
Efficacy and safety of plasma exchange: ann 11-year single-center experience of 2730 procedures in 317 patients.
Transfus. Apher. Sci.. 2014 Oct;51(2):209-14, PMID: 25217991
We reviewed retrospectively 317 patients who received 2730 plasma exchange (PE) procedures. According to guidelines published by the American Society for Apheresis (ASFA) in 2013, there were 220 (69%), 55 (17%), 32 (9%), and 7 (4%) patients who were treated with PE for a disease or condition considered as category I, II, III, and IV, respectively. Overall, 73%, 72%, and 69% of the patients showed an improvement of the underlying disease or condition at the end of the PE, and at 3 months and at 6 months after finishing the PE, respectively. We observed adverse effects in 90 (3%) PEs.
HEMATOLOGY
An initiative of
